Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 June 2021 | Story Xolisa Mnukwa | Photo Supplied
UFS Food Environment Office - Improving student well-being through collaborative food provisioning initiatives.

Food insecurity plagues students across universities worldwide, and the University of the Free State (UFS) is not exempt from this plight, with research findings indicating that more than 64% of students at the university go through periods of hunger each year.

In conjunction with national Youth Month this year, the UFS reflects on the initiatives established by the university to address food insecurity across the Bloemfontein, South, and Qwaqwa campuses to help care for and support young people for the duration of their academic careers.

UFS Food Environment Office 

Annelize Visagie from the Division of Student Affairs (DSA), who is heading the Food Environment Office at the UFS, stated that a Memorandum of Understanding (MOU) was signed with Tiger Brands and Gift of the Givers last year to sponsor food parcels to students who do not have bursaries every month. Visagie further explained that UFS staff members are working hard to implement initiatives and obtain sponsorships – such as the one with Tiger Brands and Gift of the Givers – as well as food donations to ensure that students do not go hungry.

In a study that Visagie conducted in 2019 with first-year students as the focus, it was found that academic performance declines and coping mechanisms increase as the severity of food insecurity increases.

“Students use different coping mechanisms, with an alarming 40,6% of them resorting to fasting as an excuse to friends for not having food. Sixty percent of them skip meals because they do not have enough money, and 43,2% of them are too embarrassed to ask for help,” explained Visagie. 

 Various factors contribute to this scenario, with the main reason being that most students come from impoverished economic and social circumstances. This suggests that although students may receive NSFAS funding or any other bursary, it is not a guarantee that they are food secure.

UFS Food Insecurity Support initiatives

There are many students who lack adequate financial support to sustain them through their academic careers at university. 

The UFS No Student Hungry (NSH) Programme under the UFS Division of Student Affairs (DSA) provides students in need with modest food allowances and daily access to one balanced meal. Students are selected in terms of financial need, participation in student life, and a commitment to giving back to the community. The programme allows students to focus on their studies without worrying about their next meal – increasing their chances to excel academically and ultimately obtain their degrees. 

According to Dr WP Wahl, Head of Student Life in the DSA, the division encourages innovation to meet the challenges of food insecurity and malnutrition among students. Several student volunteers and student governance structures are collaborating with the DSA on various initiatives. 

Students from residences and other student communities have planted vegetable gardens on the Bloemfontein Campus with the assistance of KovsieACT and the Faculty of Natural and Agricultural Sciences, where students and staff continuously harvest and distribute vegetables to needy students on a weekly basis.  The construction of these gardens was financed by a collaboration with Tiger Brands and Siyakhana Food Gardens, who have assisted with the training of students and consultation throughout the project.

The continuation of the food parcel project and other support initiatives facilitated by the Food Environment Office thrive through collaborations with businesses, NPOs, UFS students, and DSA staff to address food insecurity and malnutrition among students. Staff and students are encouraged to contribute by also collecting non-perishable food items for the UFS Food Environment Office.

To apply for support, or to contribute, contact the Food Environment Office or Annelize Visagie

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept